New pill could help shed pounds without surgery

NCT ID NCT07274137

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental oral drug called MDR-001 to help adults with overweight or obesity lose weight over 52 weeks. About 738 participants will receive either the drug or a placebo, along with lifestyle advice. The main goal is to see if the drug leads to meaningful weight loss compared to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Central Hospital Affiliated To Shangdong First Medical University

    Jinan, China

  • Central Hospital of Jin zhou

    Jinzhou, China

  • Dongyang People's Hospital

    Dongyang, China

  • First Hospital of Shanxi Medical University

    Taiyuan, China

  • Ganzhou People's Hospital

    Ganzhou, China

  • Huizhou Central People's Hospital

    Huizhou, China

  • Huizhou Third People's Hospital

    Huizhou, China

  • Huzhou Central Hospital

    Huzhou, China

  • Jingzhou Hospital Affiliated to Yangtze University

    Jinzhou, China

  • JiuJiang No.1 people's Hospital

    Jiujiang, China

  • Lianyungang Hospital of TCM

    Lianyungang, China

  • Liaocheng People's Hospital

    Liaocheng, China

  • Loudi Central Hospital

    Loudi, China

  • PKUCare Luzhong Hospital

    Zibo, China

  • Peking University People's Hospital

    Beijing, China

  • People's Hospital of Hunan Province

    Changsha, China

  • Pingxiang People's Hospital

    Pingxiang, China

  • Sanya Central Hospital (Hainan Third People's Hospital)

    Sanya, China

  • Shanxi Bethune Hospital

    Taiyuan, China

  • Shenyang Fifth People Hospital

    Shenyang, China

  • Shenyang Sixth People's Hospital

    Shenyang, China

  • Siping Central People's Hospital

    Siping, China

  • Taizhou Hospital of Zhejiang province

    Taizhou, China

  • The First Affiliated Hospital of Ningbo University

    Ningbo, China

  • The First Affiliated Hospital of Soochow University

    Suzhou, China

  • The First People's Hospital of Changde City

    Changde, China

  • The Fourth Hospital of Changsha

    Changsha, China

  • The People's Hospital of liaoning Province

    Shenyang, China

  • The Second Affiliated Hospital of ZhengzhouUniversity

    Zhengzhou, China

  • The Second Hospital of Anhui Medical University

    Hefei, China

  • The Second Hospital of Hebei Medical University

    Shijia Zhuang, China

  • The Second Hospital of Jilin University

    Changchun, China

  • The SecondPeople's Hospital of Hefei

    Hefei, China

  • The Third Affiliated Hospital of Jinzhou Medical University

    Jinzhou, China

  • The Third People's Hospital of Datong

    Datong, China

  • The Third People's Hospital of Zhengzhou

    Zhengzhou, China

  • Wuhan Third Hospital•Tongren Hospital of Wuhan University

    Wuhan, China

  • Xiangya Hospital Zhuzhou Central South University

    Zhuzhou, China

  • Xuancheng People's Hospital

    Xuancheng, China

  • Yichang Central People's Hospital

    Yibin, China

  • Yichang Central People's Hospital

    Yichang, China

  • Yueyang Central Hospital

    Yueyang, China

  • Yueyang People's Hospital

    Yueyang, China

  • Zibo Central Hospital

    Zibo, China

  • Zibo Municipal Hospital

    Zibo, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.